Group 1 - The core point of the news is that Guorui Life (00108) has announced a non-binding letter of intent regarding the potential acquisition of 100% equity in a digital healthcare service company, with a total consideration of approximately RMB 269 million (around HKD 294.8 million) [1] - The acquisition will be executed through the issuance of 147 million consideration shares at an issue price of HKD 1.6 per share, subject to certain conditions [1] - The stock price of Guorui Life fell over 4% to HKD 3.82, with a trading volume of HKD 26.43 million at the time of reporting [1] Group 2 - On December 5, 2025, four agreements were established between the Chinese operating entity and the seller, including a share purchase agreement, cash purchase agreement, Class A subscription agreement, and Class B subscription agreement [2] - The share purchase agreement will take effect immediately upon formal signing by the company, the Chinese operating entity, and the seller, but will terminate if necessary ODI approvals are not obtained within 365 days [2] - The cash purchase agreement will only become effective if the share purchase agreement is terminated, serving as an alternative settlement arrangement for the proposed acquisition [2]
港股异动 | 国锐生活(00108)尾盘跌超4% 近日拟2.69亿元收购北京春雨天下软件已发行股本总额约78.3%